VACCINE safetyCOVID-19 pandemicPEDIATRICSCOVID-19To date, COVID-19 has infected more than 200 million people worldwide, with 4 million having died because of it. The infection rate among pediatrics was 14.2% of the total COVID-19 cases. One of the effective tools for stopping ...
Years from now, today’s children will tell the next generation about their experiences during the coronavirus disease 2019 (COVID-19) pandemic. What they recount will depend on how old they are currently and the circumstances in which they currently live. If an effective vaccine is developed s...
vaccine trials (Roush, 2020). Early results from trials onadult volunteers (Pf i zer Inc., Moderna Inc., AstraZeneca, etc.) are prom-ising, and manufacturers are moving swiftly to obtain Food and DrugAdministration(FDA)emergency approvalfor distribution to thepublic(Abbasi, 2020; Molteni, 2020...
Due to the low numbers of hospitalized children ages 5-11 years in the study, researchers could not analyze vaccine effectiveness by disease severity for this age group but will continue to monitor as these data are collected. Data in this age group was not available for the Delta period,...
critical care physician at Ann & Robert H. Lurie Children's Hospital of Chicago and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. "It is difficult to predict whether the vaccine will be as effective against the current subvariant of Omicron, but most lik...
“This study provides us with important data showing the protective effects of the vaccine against long-haul COVID and suggests that this protection is mostly from preventing visible infections,” said senior researcherDr. Charles Bailey, an associate professor of pediatrics with the Children’s Hospi...
Although this technology has been studied for decades, widespread use of mRNA vaccines is new. They don't use the live coronavirus that causes COVID-19. The mRNA in the vaccine gets into the cells where the shot is given. Then it gives the cells instructions on how to create a piece of...
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
Biotech Innovations October 12, 2021 India’s New COVID-19 DNA Vaccine for Adolescents and Adults Is a First Jennifer Abbasi JAMA. 2021;326(14):1365. doi:10.1001/jama.2021.16625 COVID-19 Resource Center related articles icon Related Articles Medical News & Perspectives COVID-19 and mRNA ...
In this issue of JAMA Pediatrics, Watanabe and coauthors1 evaluated the safety and efficacy of 2 doses of Pfizer’s messenger RNA (mRNA) vaccine in children aged 5 to 11 years during both the delta and omicron waves of COVID-19. In a systematic review and meta-analysis that included 17...